The previous page is sending you to https://www.jnj.com/media-center/press-releases/janssen-cilag-international-nv-janssen-submits-european-marketing-authorisation-application-for-investigational-multi-drug-resistant-tuberculosis-treatment-bedaquiline.

 If you do not want to visit that page, you can return to the previous page.